Solid Lipid Nanoparticles in Medicine: Formulation, Characterization and Future prospects

Year : 2025 | Volume : 02 | Issue : 01 | Page : 1-15
    By

    sumaiya Hasim Inamdar,

  • Shravni Sunil Kothawale,

  • Rutuja Ramachandra Mane,

  • Pramod Mahodey Kale,

  • Shrivardhan Mahesh Bolaj,

  1. Student, Department of Pharmacy,Shree Ambabai Talim Sanstha, Tilaknagar, Miraj- Sangli Road, Miraj Dist- Sangli, Maharashtra, India
  2. Student, Department of Pharmacy,Shree Ambabai Talim Sanstha, Tilaknagar, Miraj- Sangli Road, Miraj Dist- Sangli, Maharashtra 416410, India
  3. Student, Department of Pharmacy,Shree Ambabai Talim Sanstha, Tilaknagar, Miraj- Sangli Road, Miraj Dist- Sangli, Maharashtra 416410, India
  4. Lecturer, Department of Pharmacy,Shree Ambabai Talim Sanstha, Tilaknagar, Miraj- Sangli Road, Miraj Dist- Sangli, Maharashtra 416410, India
  5. Lecturer, Department of Pharmacy,Shree Ambabai Talim Sanstha, Tilaknagar, Miraj- Sangli Road, Miraj Dist- Sangli, Maharashtra 416410, India

Abstract

An alternative to conventional colloidal carriers such liposomes, polymeric nanoparticles, and emulsions, solid lipid nanoparticles (SLNs) were created in the early 1990s. Benefits include targeted medicine distribution, controlled drug release, and improved stability. An extensive review of the excipients utilized, the production techniques, including the membrane contractor approach, and the possible advantages and disadvantages of SLNs is given in this work. It investigates secondary stabilization techniques like freeze-drying and spray-drying, as well as elements of SLN stability and the function of various excipients in preserving stability. There is a detailed analysis of the difficulties in producing SLN and the instrumental methods used. Particular attention is paid to drug incorporation models in SLNs, their release processes, and the analytical techniques employed to assess them. Targeted medication delivery is one of the main uses of SLNs that are highlighted in the research. The different solid lipid-based nanocarrier types—solid lipid nanoparticles, nanostructured lipid carriers, and lipid drug conjugates—as well as their structural variants are investigated. Large-scale synthesis of solid lipid nanoparticles is described using a variety of production methods. For the purpose of characterizing solid lipid nanoparticles, photon correlation spectroscopy, scanning electron microscopy, and differential scanning calorimetry are suggested as appropriate analytical techniques. The biodistribution and mode of delivery of solid lipid nanoparticles are also discussed. Solid lipid nanoparticles could transform complicated medical conditions.

Keywords: Solid lipid Nanoparticles, Homogenizer, Hydrophilic, Nanoparticle, Bioavailability.

[This article belongs to International Journal of Membranes ]

How to cite this article:
sumaiya Hasim Inamdar, Shravni Sunil Kothawale, Rutuja Ramachandra Mane, Pramod Mahodey Kale, Shrivardhan Mahesh Bolaj. Solid Lipid Nanoparticles in Medicine: Formulation, Characterization and Future prospects. International Journal of Membranes. 2025; 02(01):1-15.
How to cite this URL:
sumaiya Hasim Inamdar, Shravni Sunil Kothawale, Rutuja Ramachandra Mane, Pramod Mahodey Kale, Shrivardhan Mahesh Bolaj. Solid Lipid Nanoparticles in Medicine: Formulation, Characterization and Future prospects. International Journal of Membranes. 2025; 02(01):1-15. Available from: https://journals.stmjournals.com/ijm/article=2025/view=203476


References

  1. Nadkar S, Lokhande C. Current Trends in Novel Drug Delivery- An OTC Perspective. Pharma Times 2010; 42(Suppl 4):17-23.
  2. Loxley A. Solid Lipid Nanoparticles for the Delivery of Pharmaceutical Actives. Drug Delivery Technology 2009; 9(Suppl 8):32.
  3. Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types, and applications toward targeted drug delivery. Nanomedicine: NMB 2010; 6(Suppl 1):e9-e24.
  4. Maravajhala V, Papishetty S, Bandlapalli S. Nanotechnology in Development of Drug Delivery System. International Journal of Pharmaceutical Science and Research 2011; 3(Suppl 1):84-96.
  5. Ekambaram P, Sathali AH, Priyanka K. Solid Lipid Nanoparticles: A Review. Scientific Reviews and Chemical Communication 2012; 2(Suppl 1):80-102.
  6. Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery—A review of the state of the art. European Journal of Biopharmaceutics 2000; 50:161-177.
  7. Mandawgade SD, Patravale VB. Development of SLNs from natural lipids: Application to topical delivery of tretinoin. International Journal of Pharmaceutics 2008; 363:132-138.
  8. Helgason T, Awad TS, Kristbergsson K, McClements DJ, Weiss J. Effect of surfactant surface coverage on the formation of solid lipid nanoparticles (SLN). Journal of Colloid and Interface Science 2009; 334:75-81.
  9. Sinha VR, Srivastava S, Goel H, Jindal V. Solid Lipid Nanoparticles (SLNs): Trends and Implications in Drug Targeting. International Journal of Advances in Pharmaceutical Sciences 2010; 1:212-238.
  10. Mehnert W, Mader K. Solid lipid nanoparticles—Production, characterization, and applications. Advanced Drug Delivery Reviews 2001; 47:165-196.
  11. Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Advanced Drug Delivery Reviews 2002; 54(Suppl 1):131-155.
  12. Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Advanced Drug Delivery Reviews 2008; 60:734-746.
  13. Chakraborty S, Shukla D, Mishra B, Singh S. Lipid: An emerging platform for oral delivery of drugs with poor bioavailability. European Journal of Pharmaceutics and Biopharmaceutics 2009; 73:1-15.
  14. Manjunath K, Venkateswarlu V. Preparation, Characterization, and In Vitro Release Kinetics of Clozapine Solid Lipid Nanoparticles. Journal of Controlled Release 2004; 95:627-638.
  15. Hu FQ, Yuan H, Zhang HH, Fang M. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. International Journal of Pharmaceutics 2002; 239:121-128.
  16. Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. International Journal of Pharmaceutics 2003; 257:153-160.
  17. Yuan H, Huang L, Du Y, Ying X, You J, Hu F, Zeng S. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Colloids and Surfaces B: Biointerface 2008; 61:132-137.
  18. Wissing SA, Kayser O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Advanced Drug Delivery Reviews 2004; 56:1257-1272.
  19. Kuo YC, Chen HH. Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. International Journal of Pharmaceutics 2009; 365:206-213.
  20. Lv Q, Yu A, Xi Y, Li H, Song Z, Cui J, Cao F, Zhai G. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. International Journal of Pharmaceutics 2009; 372:191-198.
  21. Cavalli R, Donalisio M, Civra A, Ferruti P, Ranucci E, Trotta F, Lembo D. Enhanced antiviral activity of Acyclovir loaded into B-cyclodextrin-poly (4-acryloylmorpholine) conjugate nanoparticles. Journal of Controlled Release 2009; 137:116-122.
  22. Pandita D, Ahuja A, Velpandian T, Lather V, Dutta T, Khar RK. Characterization and in vitro assessment of paclitaxel-loaded lipid nanoparticles formulated using a modified solvent injection technique. Pharmazie 2009; 64:301-310.
  23. Shah M, Pathak K. Development and Statistical Optimization of Solid Lipid Nanoparticles of Simvastatin by Using 2³ Full-Factorial Design. AAPS PharmSciTech 2010; 11(Suppl 2):489-496.
  24. Charcosset C, El-Harati A, Fessi H. Preparation of solid lipid nanoparticles using a membrane contactor. Journal of Controlled Release 2005; 108:112-120.
  25. Ohshima H, Miyagishima A, Kurita T, Makino Y, Iwao Y, Sonobe T, Itai S. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution. International Journal of Pharmaceutics 2009; 377:180-184.
  26. Subedi RK, Kang KW, Choi KH. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. European Journal of Pharmaceutical Sciences 2009; 37:508-513.
  27. Dong X, Mattingly CA, Tseng M, Cho M, Adams VR, Mumper RJ. Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization. European Journal of Pharmaceutics and Biopharmaceutics 2009; 72:9-17.
  28. Freitas C, Muller RH. Spray-drying of solid lipid nanoparticles (SLN-TM). European Journal of Pharmaceutics and Biopharmaceutics 1998; 46:145-151.
  29. Shah CV, Shah V, Upadhyay U. Solid Lipid Nanoparticles: A Review. Current Pharma Research 2011; 1(Suppl 4):351-368.
  30. Kaur IP, Bhandari R, Bhandari S, Kakkar V. Potential of solid lipid nanoparticles in brain targeting. Journal of Controlled Release 2008; 127:97-109.
  31. Mudshinge SR, Deore AB, Patil S, Bhalgat CM. Nanoparticles: Emerging carriers for drug delivery. Saudi Pharmaceutical Journal 2011; 24:129-141.
  32. Joshi MD, Müller RH. Lipid nanoparticles for parenteral delivery of actives. European Journal of Pharmaceutics and Biopharmaceutics 2009; 71:161-172.
  33. Gonnet M, Lethuaut L, Boury F. New trends in encapsulation of liposoluble vitamins. Journal of Controlled Release 2010; 146:276-290.
  34. Jawahar N, Gowthamarajan K, Meyyanathan SN, Sood S. Brain delivery by solid lipid nanoparticles for CNS drugs. International Journal of Pharmaceutical Research and Development 2011; 3(Suppl 4):206-216.
  35. Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: The need for precision in reporting particle size parameters. European Journal of Pharmaceutics and Biopharmaceutics 2008; 69:1-9.
  36. Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mader K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-based solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation, and transmission electron microscopy. Journal of Controlled Release 2004; 95:217-227.
  37. Schubert MA, Muller-Goymann CC. Characterization of surface-modified solid lipid nanoparticles (SLN): Influence of lecithin and nonionic emulsifier. European Journal of Pharmaceutics and Biopharmaceutics 2005; 61:77-86.
  38. Ye J, Wang Q, Zhou X, Zhang N. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. International Journal of Pharmaceutics 2008; 352:273-279.
  39. Huang G, Zhang N, Bi X, Dou M. Solid lipid nanoparticles of temozolomide: Potential reduction of cardiac and nephric toxicity. International Journal of Pharmaceutics 2008; 255:314-320.
  40. Elnaggar YSR, El-Massik MA, Abdallah OY. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. International Journal of Nanomedicine 2011; 6:3195-3205.
Regular Issue Subscription Review Article
Volume 02
Issue 01
Received 24/10/2024
Accepted 05/03/2025
Published 10/03/2025
Publication Time 137 Days
Total Visits: 142


My IP

PlumX Metrics